Recommended Ephedra/Guarana Doses Show Harm in Haller Study

Recommended doses of ephedra/guarana combinations resulted in "persistent increases" in heart rate and blood pressure as well as "unfavorable actions" on glucose and potassium homeostasis in a small clinical study published in the June Clinical Pharmacology & Therapeutics.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet